logo

For the Inventor, By the Inventor

Madison, WI, United States of America

Cellectar, Inc.

Calculating rank
USPTO Granted Patents = 12


Forward Citations = 125

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Jamey Paul Weichert (12 out of 45 patents)

silverMedal Marc Longino (12 out of 20 patents)

bronzeMedal Anatoly Pinchuk (10 out of 30 patents)

4.  Irawati Kandela (4 out of 5 patents)

5.  William R Clarke (4 out of 7 patents)

6.  Sharon Weber (1 out of 1 patent)

7.  Joseph O Nwankwo (1 out of 1 patent)


12 patents:

1. 10004818 - Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer (2018-06-26),
2. 9339564 - Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer (2016-05-17),
3. 8877160 - Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof (2014-11-04),
4. 8877159 - Phospholipid analogs as diapeutic agents and methods thereof (2014-11-04),
5. 8871181 - Fluorescent phospholipid ether compounds, compositions, and methods of use (2014-10-28),
6. 8540968 - Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof (2013-09-24),
7. 8535641 - Phospholipid analogs as diapeutic* agents and methods thereof (2013-09-17),
8. 8022235 - Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use (2011-09-20),
9. 7893286 - Method for the synthesis of phospholipid ethers (2011-02-22),
10. 7811548 - Fluorescent phospholipid ether compounds and compositions (2010-10-12),
11. 7700075 - Virtual colonoscopy with radiolabeled phospholipid ether analogs (2010-04-20),
12. 7632644 - Imaging and selective retention of phospholipid ether analogs (2009-12-15),
Company Overview
Cellectar, Inc. is a biotechnology company based in Madison, Wisconsin, specializing in the development of innovative therapies for cancer treatment. The company focuses on its proprietary phospholipid drug conjugate (PDC) platform, which aims to enhance the delivery of therapeutic agents directly to cancer cells while minimizing effects on healthy tissues. Cellectar's research encompasses targeted therapies designed to address various types of cancer, leveraging advanced drug delivery mechanisms to improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Cellectar, Inc. USPTO Patent Assignee Logo
12 Patents

#61 in Madison, WI

#577 in Wisconsin

#25,589 in US

#48,235 in the World

Madison, WI (US)
Madison, WI, United States of America

Cellectar, Inc.

Forward Citations = 125

7 inventors:

goldMedal Jamey Paul Weichert (12 out of 45 patents)

silverMedal Marc Longino (12 out of 20 patents)

bronzeMedal Anatoly Pinchuk (10 out of 30 patents)

4.  Irawati Kandela (4 out of 5 patents)

5.  William R Clarke (4 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cellectar, Inc.. Retrieved from https://idiyas.com/company/cellectar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…